Cubist Pharmaceuticals

Cubist Pharmaceuticals, Inc.
Company typeSubsidiary
Nasdaq: CBST
IndustryPharmaceuticals (Biopharmaceuticals & Biotherapeutics)
Founded1992 (1992)
Defunct2015 (2015)
HeadquartersLexington, Massachusetts
Key people
Robert J. Perez (president & CEO)
ProductsProduct Pipeline
Revenue $926.4 million USD (2012)
ParentMerck & Co.
Websitewww.cubist.com

Cubist Pharmaceuticals, Inc. was an American biopharmaceutical company that targeted pathogens like MRSA.

. The company employed 638 people, mostly in Lexington, Massachusetts. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion).

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.